Business · 08/12/2005
FDA Releases Draft Guidance for Nucleic Acid Based In Vitro Diagnostic Devices
The FDA is releasing a draft guidance document to provide guidance on preparing premarket submissions for nucleic acid based in vitro diagnostic devices that detect microbial pathogens.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →